Mainz Epilepsy Registry

Learn more about:
Related Clinical Trial
Patient-reported Outcome After Status Epilepticus Point-of-care EEG in the Pediatric Emergency Department eegCap Application in Paediatrics wiTh redUced GCS in REsus Mainz Epilepsy Registry Assessment of Adults Epidemiological Characteristics of Status Epilepticus in the French West Indies and in French Guiana Repeated TMS at Low Frequencies to Reduce Seizure Occurrence VIGAB-BIOSTAT: Neuronal Injury Panel Substudy Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children Comparison of Efficacy of Phenytoin With Levetireacetam for the Management of Children With Status Epilepticus Tracheostomy With Bedside Simultaneous Gastrostomy Vs Usual Care Tracheostomy And Delayed Gastrostomy Placement Phase 1, Open-label, Comparison Study of a Single IM Dose of Midazolam Using an Auto-injector vs a Marketed Midazolam Vial in Healthy Adults COVID-19 Brain Injury RAndomized Therapy In Status Epilepticus Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment Assessment of Severity and Prognosis for Patients With Status Epileptics(SE) Simulation RCT of Telemedical Support for Paramedics Seizure Rescue Medication: Caregiver Education in a Simulation Setting EEG in In-hospital Patients With Seizure or Altered Mental State Smartphone Apps for Pediatric Resuscitation Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children. Putting Electroencephalography (EEG) in the Emergency Department Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2) LORA-PITA IV General Investigation Creation, Implementation, and Analysis of a Seizure Action Plan Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus Lorazepam for the Treatment of Status Epilepticus in Children Diagnostic Value of Prehospital EEG in Non-convulsive Status Epilepticus TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus Ketogenic Diet for Refractory Status Epilepticus Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus Improving Emergency Management of Status Epilepticus A Clinical Study of Children With Status Epilepticus in China Prognosis Factors Associated With Convulsive Status Epilepticus in Adults Management of Non Convulsive Status Epilepticus EEG Monitoring for Refractory Status Epilepticus SURESTEP: Transcranial Direct Current Stimulation in Super Refractory Status Epilepticus Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus Treatment of Refractory Status Epilepticus Status Epilepticus in the Critically Ill Patients Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures Ketamine in Refractory Convulsive Status Epilepticus Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan

Brief Title

Mainz Epilepsy Registry

Official Title

Study on Disease Course and Quality of Life in Patients With Epilepsy (Mainz Epilepsy Registry)

Brief Summary

      Prospective longitudinal observational registry study of all patients with epilepsy treated
      in the Mainz Comprehensive Epilepsy and Sleep Medicine Center with the focus on the course of
      the disease and quality of life.
    

Detailed Description

      Clinical parameters of patients, such as onset of the disease, prior medication, disease
      severity, which are important for the data analysis also collected retrospectively before the
      initiation of the registry. Data on the quality of life is collected only prospectively.
    


Study Type

Observational [Patient Registry]


Primary Outcome

monthly seizure frequency after 6 months

Secondary Outcome

 Resilience Scale 13

Condition

Epilepsy

Intervention

no interventions, only observation


Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Other

Estimated Enrollment

700

Start Date

February 1, 2018

Completion Date

January 31, 2024

Primary Completion Date

January 31, 2024

Eligibility Criteria

        Inclusion Criteria:

          -  Epileptic or psychogenic seizures

        Exclusion Criteria:

          -  age<18

          -  patients who cannot provide informed consent and don't have a legal guardian
      

Gender

All

Ages

18 Years - N/A

Accepts Healthy Volunteers

No

Contacts

Yaroslav Winter, MD, MSc, +496131172234, [email protected]

Location Countries

Germany

Location Countries

Germany

Administrative Informations


NCT ID

NCT05267405

Organization ID

MAINZ-EPIREG


Responsible Party

Principal Investigator

Study Sponsor

Johannes Gutenberg University Mainz


Study Sponsor

Yaroslav Winter, MD, MSc, Principal Investigator, Mainz Comprehensive Epilepsy and Sleep Medicine Center


Verification Date

February 2022